United-Guardian (UG)
NASDAQ:UG
Top Page
United-Guardian
(NASDAQ:UG)
Select Model
Select Model
Rating:74Outperform
Price Target:
$7.50
▲(20.58% Upside)
Action:ReiteratedDate:03/29/26
The score is driven primarily by strong financial quality—especially the debt-free balance sheet and healthy margins—tempered by a recent step-down in 2025 revenue/earnings/cash flow. Valuation is supportive given a modest P/E and very high dividend yield, while technical indicators are neutral-to-soft with price below the 200-day average and slightly negative MACD. A positive corporate update around sustained dividends and growth initiatives provides an additional, smaller lift.
Positive Factors
Debt-free Balance Sheet
A zero-debt balance sheet gives the company durable financial flexibility: it can fund distribution deals, product development, and dividends from internal resources, withstand demand volatility without refinancing risk, and prioritize capital allocation for strategic growth.
Negative Factors
2025 Revenue and Earnings Step-down
A meaningful decline in 2025 results shows deterioration in demand or pricing that reduces operating leverage. If the step-down persists it can compress reinvestment capacity and pressure margins and dividends, increasing execution risk for the firm's growth initiatives.
Read all positive and negative factors
Positive Factors
Negative Factors
Debt-free Balance Sheet
A zero-debt balance sheet gives the company durable financial flexibility: it can fund distribution deals, product development, and dividends from internal resources, withstand demand volatility without refinancing risk, and prioritize capital allocation for strategic growth.
Read all positive factors
United-Guardian (UG) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$29.91M
Dividend Yield9.81%
Average Volume (3M)6.29K
Price to Earnings (P/E)13.4
Beta (1Y)0.35
Revenue Growth-18.29%
EPS Growth-43.76%
CountryUS
Employees24
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)0.14
Shares Outstanding4,594,319
10 Day Avg. Volume6,994
30 Day Avg. Volume6,291
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)2.52
Price to Sales (P/S)2.68
P/FCF Ratio14.83
Enterprise Value/Market Cap0.96
Enterprise Value/Revenue2.72
Enterprise Value/Gross Profit5.69
Enterprise Value/Ebitda12.19
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
United-Guardian Business Overview & Revenue Model
Company Description
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally. The company offers cosmetic ingredients, including LU...
How the Company Makes Money
United-Guardian makes money primarily by selling specialty chemical products/ingredients and related formulations to business customers, generating revenue from product shipments recognized as sales. Key revenue streams come from (1) personal care...
United-Guardian Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
90
Very Positive
Cash Flow
78
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 10.55M | 12.18M | 10.89M | 12.70M | 13.93M |
| Gross Profit | 5.03M | 6.46M | 5.41M | 6.70M | 8.18M |
| EBITDA | 2.35M | 3.74M | 2.97M | 4.17M | 5.81M |
| Net Income | 2.11M | 3.25M | 2.58M | 2.57M | 4.66M |
Balance Sheet | |||||
| Total Assets | 13.46M | 13.80M | 12.92M | 10.64M | 12.24M |
| Cash, Cash Equivalents and Short-Term Investments | 8.57M | 9.40M | 9.09M | 6.48M | 8.17M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 2.23M | 1.91M | 1.53M | 1.37M | 2.42M |
| Stockholders Equity | 11.23M | 11.88M | 11.39M | 9.27M | 9.82M |
Cash Flow | |||||
| Free Cash Flow | 1.91M | 3.03M | 2.98M | 2.45M | 5.20M |
| Operating Cash Flow | 1.97M | 3.47M | 3.14M | 2.53M | 5.31M |
| Investing Cash Flow | 175.34K | -7.08M | 4.73M | 897.56K | -183.47K |
| Financing Cash Flow | -2.77M | -2.76M | -459.39K | -3.12M | -5.19M |
United-Guardian Technical Analysis
Neutral
6.22
Price Trends
6.58
Negative
6.23
Positive
6.95
Negative
Market Momentum
<0.01
Negative
50.73
Neutral
70.09
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For UG, the sentiment is Neutral. The current price of 6.22 is below the 20-day moving average (MA) of 6.46, below the 50-day MA of 6.58, and below the 200-day MA of 6.95, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 50.73 is Neutral, neither overbought nor oversold. The STOCH value of 70.09 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for UG.
United-Guardian Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $29.91M | 13.44 | 19.09% | 9.81% | -18.29% | -43.76% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
54 Neutral | $170.57M | 14.99 | 8.95% | 1.48% | 2.35% | -50.52% | |
48 Neutral | $53.37M | -3.67 | -130.15% | ― | -15.42% | 7.12% | |
47 Neutral | $9.74M | ― | 16.79% | ― | 7.75% | -21.61% | |
46 Neutral | $11.01M | 2.46 | -19.54% | ― | -9.17% | -4.64% | |
45 Neutral | $115.66M | -5.47 | -15.42% | ― | -13.14% | 57.98% |
* Consumer Defensive Sector Average
UG
United-Guardian
6.51
-1.24
-15.99%
ACU
Acme United
44.79
9.09
25.46%
MTEX
Mannatech
5.79
-2.58
-30.82%
SKIN
Beauty Health
0.91
-0.14
-13.40%
GROV
Grove Collaborative Holdings
1.27
0.03
2.42%
TKLF
Yoshitsu Co. Ltd. Sponsored ADR
2.30
-0.72
-23.84%
United-Guardian Corporate Events
Business Operations and StrategyDividends
United-Guardian Declares Quarterly Dividend, Highlights Growth Initiatives
Positive
Jan 29, 2026
On January 26, 2026, the board of United-Guardian, Inc. declared a cash dividend of $0.25 per share, marking the 31st consecutive year the company has paid a dividend, with payment scheduled for February 17, 2026 to shareholders of record as of Fe...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.